Literature DB >> 16645796

'Medicine's next goldmine?' The implications of new genetic health technologies for the health service.

Michael Calnan1, David Wainwright, Peter Glasner, Ruth Newbury-Ecob, Ewan Ferlie.   

Abstract

There is considerable uncertainty about the implications of the new genetics for health services. These are the enthusiasts who argue that molecular genetics will transform health care and others argue that the scope for genetic interventions is limited. The aim of this paper is to examine some of the questions, tensions and difficulties which face health care providers particularly in developed countries as they try to come to terms with the dilemmas raised by new genetic health care technologies (NGHTs). It identifies questions for research which may help the development of robust and flexible strategies for implementation.

Entities:  

Mesh:

Year:  2006        PMID: 16645796     DOI: 10.1007/s11019-005-7496-2

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  27 in total

1.  Gene therapy experiments put on "clinical hold".

Authors:  J Ciment
Journal:  BMJ       Date:  2000-02-05

2.  Applying research to health care policy and practice: medical and managerial views on effectiveness and the role of research.

Authors:  R Rosen
Journal:  J Health Serv Res Policy       Date:  2000-04

3.  Improving the quality of health care in the United Kingdom and the United States: a framework for change.

Authors:  E B Ferlie; S M Shortell
Journal:  Milbank Q       Date:  2001       Impact factor: 4.911

4.  The impact of the UK NHS purchaser-provider split on the 'rational' introduction of new medical technologies.

Authors:  R Rosen; N Mays
Journal:  Health Policy       Date:  1998-02       Impact factor: 2.980

Review 5.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

6.  No magic targets! Changing clinical practice to become more evidence based.

Authors:  Sue Dopson; Louise FitzGerald; Ewan Ferlie; John Gabbay; Louise Locock
Journal:  Health Care Manage Rev       Date:  2002

7.  The governance of human genetics: policy discourse and constructions of public trust.

Authors:  Mavis Jones; Brian Salter
Journal:  New Genet Soc       Date:  2003-04

8.  How acceptable are innovative health-care technologies? A survey of public beliefs and attitudes in England and Wales.

Authors:  Michael Calnan; David Montaner; Rob Horne
Journal:  Soc Sci Med       Date:  2004-11-13       Impact factor: 4.634

9.  Disenchantment, ambivalence, and the precautionary principle: the becalming of British health policy.

Authors:  D Wainwright
Journal:  Int J Health Serv       Date:  1998       Impact factor: 1.663

10.  Medical technology and professional dominance theory.

Authors:  A L Greer
Journal:  Soc Sci Med       Date:  1984       Impact factor: 4.634

View more
  3 in total

1.  The helix in the labyrinth: do we need genetic health services and policy research?

Authors:  Fiona Alice Miller; Brenda Wilson; Jeremy Grimshaw; Renaldo Battista; Ingeborg Blancquaert; June C Carroll; François Rousseau; Barbara Slater
Journal:  Healthc Policy       Date:  2008-08

Review 2.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

3.  Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of GPs' experiences.

Authors:  Vicki Tsianakas; Michael Calnan; Karl Atkin; Elizabeth Dormandy; Theresa M Marteau
Journal:  Br J Gen Pract       Date:  2010-11       Impact factor: 5.386

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.